229.02 - 234.51
169.21 - 260.10
55.82M / 54.92M (Avg.)
32.24 | 7.26
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-31.19%
Negative revenue growth while VUZI stands at 59.16%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-31.88%
Negative gross profit growth while VUZI is at 281.15%. Joel Greenblatt would examine cost competitiveness or demand decline.
-42.54%
Negative EBIT growth while VUZI is at 20.16%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-42.54%
Negative operating income growth while VUZI is at 20.16%. Joel Greenblatt would press for urgent turnaround measures.
-42.09%
Negative net income growth while VUZI stands at 20.50%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-40.95%
Negative EPS growth while VUZI is at 21.74%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-41.90%
Negative diluted EPS growth while VUZI is at 21.74%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-1.30%
Share reduction while VUZI is at 0.02%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-1.52%
Reduced diluted shares while VUZI is at 0.02%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
-2.23%
Dividend reduction while VUZI stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-58.21%
Negative OCF growth while VUZI is at 1.12%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-62.32%
Negative FCF growth while VUZI is at 6.29%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
848.55%
Positive 10Y revenue/share CAGR while VUZI is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
66.51%
5Y revenue/share CAGR above 1.5x VUZI's 12.62%. David Dodd would look for consistent product or market expansions fueling outperformance.
35.38%
3Y revenue/share CAGR under 50% of VUZI's 127.85%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
1670.28%
Positive long-term OCF/share growth while VUZI is negative. John Neff would see a structural advantage in sustained cash generation.
7.95%
Positive OCF/share growth while VUZI is negative. John Neff might see a comparative advantage in operational cash viability.
13.44%
Positive 3Y OCF/share CAGR while VUZI is negative. John Neff might see a big short-term edge in operational efficiency.
1180.49%
Net income/share CAGR above 1.5x VUZI's 48.22% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
48.15%
Positive 5Y CAGR while VUZI is negative. John Neff might view this as a strong mid-term relative advantage.
29.70%
3Y net income/share CAGR similar to VUZI's 27.97%. Walter Schloss would attribute it to shared growth factors or demand patterns.
481.16%
Equity/share CAGR of 481.16% while VUZI is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
15.40%
Below 50% of VUZI's 187.04%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
-4.27%
Negative 3Y equity/share growth while VUZI is at 30.66%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
69.50%
Dividend/share CAGR of 69.50% while VUZI is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
39.97%
3Y dividend/share CAGR of 39.97% while VUZI is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-28.94%
Firm’s AR is declining while VUZI shows 553.75%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-2.09%
Inventory is declining while VUZI stands at 3.92%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-8.49%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-9.02%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-1.83%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
1.18%
We increase R&D while VUZI cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
-6.79%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.
